nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00024	0.00024	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00024	0.00024	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00024	0.00024	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00024	0.00024	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000239	0.000239	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000239	0.000239	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000239	0.000239	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000239	0.000239	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000238	0.000238	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000237	0.000237	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000237	0.000237	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000237	0.000237	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000236	0.000236	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000235	0.000235	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000234	0.000234	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000233	0.000233	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000232	0.000232	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00023	0.00023	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000229	0.000229	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000228	0.000228	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000227	0.000227	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000226	0.000226	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000226	0.000226	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000225	0.000225	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000225	0.000225	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000225	0.000225	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000225	0.000225	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000224	0.000224	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000223	0.000223	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000223	0.000223	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000222	0.000222	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000222	0.000222	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000221	0.000221	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000221	0.000221	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000221	0.000221	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00022	0.00022	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00022	0.00022	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00022	0.00022	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00022	0.00022	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000218	0.000218	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000217	0.000217	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000217	0.000217	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000216	0.000216	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000215	0.000215	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000214	0.000214	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000214	0.000214	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000212	0.000212	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00021	0.00021	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000209	0.000209	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000208	0.000208	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000207	0.000207	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000206	0.000206	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000205	0.000205	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000205	0.000205	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	0.000205	0.000205	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000205	0.000205	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000205	0.000205	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000204	0.000204	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000204	0.000204	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000203	0.000203	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000203	0.000203	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000203	0.000203	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000203	0.000203	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000203	0.000203	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000202	0.000202	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000202	0.000202	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000202	0.000202	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.0002	0.0002	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000199	0.000199	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000199	0.000199	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000196	0.000196	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000195	0.000195	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000193	0.000193	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000192	0.000192	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000191	0.000191	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000189	0.000189	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000189	0.000189	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000189	0.000189	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000189	0.000189	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000188	0.000188	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000186	0.000186	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000186	0.000186	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000185	0.000185	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000185	0.000185	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000185	0.000185	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000185	0.000185	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000184	0.000184	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000184	0.000184	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000183	0.000183	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000183	0.000183	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000183	0.000183	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000182	0.000182	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000182	0.000182	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	0.000181	0.000181	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000181	0.000181	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000178	0.000178	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000177	0.000177	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000177	0.000177	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000176	0.000176	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000176	0.000176	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000176	0.000176	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000175	0.000175	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	0.000175	0.000175	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000174	0.000174	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000174	0.000174	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000174	0.000174	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000171	0.000171	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000171	0.000171	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00017	0.00017	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000169	0.000169	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000169	0.000169	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000168	0.000168	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000167	0.000167	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000167	0.000167	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000166	0.000166	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000163	0.000163	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000162	0.000162	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000161	0.000161	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00016	0.00016	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00016	0.00016	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000158	0.000158	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000158	0.000158	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000157	0.000157	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000157	0.000157	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000157	0.000157	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000157	0.000157	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000157	0.000157	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000157	0.000157	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000156	0.000156	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000156	0.000156	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000156	0.000156	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000155	0.000155	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	0.000155	0.000155	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000155	0.000155	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000154	0.000154	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000153	0.000153	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000153	0.000153	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000153	0.000153	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000152	0.000152	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000152	0.000152	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000151	0.000151	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000151	0.000151	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00015	0.00015	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00015	0.00015	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00015	0.00015	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000148	0.000148	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000147	0.000147	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000147	0.000147	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000146	0.000146	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000145	0.000145	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000145	0.000145	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000145	0.000145	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000145	0.000145	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000144	0.000144	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000144	0.000144	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000144	0.000144	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000143	0.000143	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	0.000142	0.000142	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000142	0.000142	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000142	0.000142	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000142	0.000142	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00014	0.00014	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000139	0.000139	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000139	0.000139	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000135	0.000135	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000135	0.000135	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	0.000135	0.000135	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000134	0.000134	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000133	0.000133	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000133	0.000133	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000132	0.000132	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000131	0.000131	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000131	0.000131	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00013	0.00013	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00013	0.00013	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00013	0.00013	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000129	0.000129	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000128	0.000128	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000128	0.000128	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000123	0.000123	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000122	0.000122	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000121	0.000121	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000121	0.000121	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000121	0.000121	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000121	0.000121	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00012	0.00012	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00012	0.00012	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00012	0.00012	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00012	0.00012	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	0.000119	0.000119	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000119	0.000119	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000119	0.000119	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000118	0.000118	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000117	0.000117	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000116	0.000116	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000116	0.000116	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000115	0.000115	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000114	0.000114	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000113	0.000113	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000111	0.000111	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00011	0.00011	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000109	0.000109	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000109	0.000109	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000104	0.000104	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000102	0.000102	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000102	0.000102	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000101	0.000101	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.0001	0.0001	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.0001	0.0001	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.98e-05	9.98e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.93e-05	9.93e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.92e-05	9.92e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.88e-05	9.88e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.86e-05	9.86e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.85e-05	9.85e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.65e-05	9.65e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.5e-05	9.5e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.37e-05	9.37e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.33e-05	9.33e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.24e-05	9.24e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.15e-05	9.15e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.97e-05	8.97e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.92e-05	8.92e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.88e-05	8.88e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.63e-05	8.63e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.55e-05	8.55e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.5e-05	8.5e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.44e-05	8.44e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.83e-05	7.83e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.71e-05	7.71e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.69e-05	7.69e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.69e-05	7.69e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.67e-05	7.67e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.64e-05	7.64e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.62e-05	7.62e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.57e-05	7.57e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.55e-05	7.55e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.35e-05	7.35e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.31e-05	7.31e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.11e-05	7.11e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.01e-05	7.01e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7e-05	7e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.46e-05	6.46e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.35e-05	6.35e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.34e-05	6.34e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.32e-05	6.32e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.3e-05	6.3e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.24e-05	6.24e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.22e-05	6.22e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.78e-05	5.78e-05	CbGpPWpGaD
